X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Procter & Gamble Health with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs DR. DATSONS LABS - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH DR. DATSONS LABS PROCTER & GAMBLE HEALTH/
DR. DATSONS LABS
 
P/E (TTM) x 60.7 -10.9 - View Chart
P/BV x 10.6 0.2 6,535.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 PROCTER & GAMBLE HEALTH   DR. DATSONS LABS
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
DR. DATSONS LABS
Mar-14
PROCTER & GAMBLE HEALTH/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs1,358126 1,080.8%   
Low Rs93331 3,019.4%   
Sales per share (Unadj.) Rs665.0133.0 500.1%  
Earnings per share (Unadj.) Rs56.60.2 37,314.1%  
Cash flow per share (Unadj.) Rs72.56.6 1,096.8%  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.7128.8 343.0%  
Shares outstanding (eoy) m16.6031.66 52.4%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x1.70.6 292.7%   
Avg P/E ratio x20.2516.1 3.9%  
P/CF ratio (eoy) x15.811.8 133.4%  
Price / Book Value ratio x2.60.6 426.7%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0112,477 767.4%   
No. of employees `0001.5NA-   
Total wages/salary Rs m1,69656 3,029.3%   
Avg. sales/employee Rs Th7,150.0NM-  
Avg. wages/employee Rs Th1,098.7NM-  
Avg. net profit/employee Rs Th608.2NM-  
INCOME DATA
Net Sales Rs m11,0404,211 262.2%  
Other income Rs m24079 304.6%   
Total revenues Rs m11,2794,289 263.0%   
Gross profit Rs m1,376569 242.0%  
Depreciation Rs m264204 129.2%   
Interest Rs m0430 0.0%   
Profit before tax Rs m1,35213 10,644.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5836 9,554.1%   
Profit after tax Rs m9395 19,564.6%  
Gross profit margin %12.513.5 92.3%  
Effective tax rate %43.148.0 89.8%   
Net profit margin %8.50.1 7,461.9%  
BALANCE SHEET DATA
Current assets Rs m7,5236,852 109.8%   
Current liabilities Rs m2,2536,711 33.6%   
Net working cap to sales %47.73.3 1,425.7%  
Current ratio x3.31.0 327.1%  
Inventory Days Days52161 32.4%  
Debtors Days Days41318 12.7%  
Net fixed assets Rs m1,2403,673 33.8%   
Share capital Rs m166317 52.4%   
"Free" reserves Rs m7,1673,761 190.6%   
Net worth Rs m7,3334,078 179.8%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m9,91212,633 78.5%  
Interest coverage xNM1.0-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.10.3 334.2%   
Return on assets %9.53.4 275.1%  
Return on equity %12.80.1 10,879.4%  
Return on capital %20.87.7 270.5%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m1,015964 105.2%   
Fx outflow Rs m3,043607 501.2%   
Net fx Rs m-2,028357 -568.2%   
CASH FLOW
From Operations Rs m5371,345 39.9%  
From Investments Rs m-476-2,256 21.1%  
From Financial Activity Rs m-220-1,200 18.3%  
Net Cashflow Rs m-160-2,111 7.6%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 0.0 -  
FIIs % 1.0 1.4 74.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 94.1 30.9%  
Shareholders   28,591 20,807 137.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON   PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (4QFY18); Net Profit Up 53.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, MERCK LTD has posted a net profit of Rs 227 m (up 53.2% YoY). Sales on the other hand came in at Rs 3 bn (up 27.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 19, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS